Castle Biosciences Inc at JMP Securities Life Sciences Conference Transcript
Thank you, everybody, for joining us for the JMP Securities Life Sciences Conference. So, the next company we have presenting is Castle Biosciences. We have Derek Maetzold, CEO; and Frank Stokes, CFO, are presenting.
Thank you, [Ryan]. Thank you for JMP Securities for organizing this conference -- in person actually.
I am going to -- have started with our standard corporate deck, which I'm going to skip through a number of slides. You can find that on our website, obviously, but we'll go and give you a quick overview, in about 20 minutes, of Castle Biosciences -- where we are today; where we think we're going tomorrow.
First of all is the disclaimer slide, which you all can read in your own time.
So, who are we? We are a molecular diagnostics company[DN1] which is focused on transforming patient care through innovative diagnostic tests, and we focus in a pattern of fours, I guess you would say.
Our first goal is to look for high unmet
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |